GLOBAL PHARMA GROUP AS

Services

/ Sales

Keywords

outreachsales activitiestelephone sales

Organization

CEO: TK
Thomas Kristoffer Storvestre1987
Chairman of the board: SE
Svein Erik Nicolaysen1963
Years since formation: 4 years; since Oct 27, 2021
Type: Limited company
VAT registered: Yes
Number of employees: 6

Ownership

Number of shares and share classes: 28,540,630; 1 share class
Total number of shareholders: 70; 23 companies, 47 persons
Belongs to group of

Financials

Total operating income 2023: 7,102,055; NOK
Annual total result 2023: -4,118,362; NOK
Total equity 2023: 12,830,581; NOK

Last update: Jan 15, 2025

Management

Management / administration

Name	Role	Shares
TK Thomas Kristoffer Storvestre 1987	Managing Director/CEO	3.04 % indirectly

Board

Name	Role	Shares
RA Rikard Arne Storvestre 1958	Alternate Member	50.11 % directly 47.43 % indirectly 2.67 %
UI Unn Irene Raknestangen Kjenslie 1958	Deputy Chair	-
PE Per Egil Sørensen 1968	Board Member	-
SE Svein Erik Nicolaysen 1963	Chairman	-

Others

Name	Role	Shares
R REVICOM AS	Auditor	-
Ø ØKORÅD ØKSNES AS	Accountant	-

Top 10 individual shareholders

Name	Role	Shares
RA Rikard Arne Storvestre 1958	Alternate Member	50.11 % directly 47.43 % indirectly 2.67 %
HR Henrik Rødsand 1960	-	14.02 % directly
TB Tom Bjarte Norland 1956	-	5.61 % indirectly
SL Silje Landevåg 1984	-	3.36 % indirectly
SL Sindre Landevåg 1988	-	3.36 % indirectly
TK Thomas Kristoffer Storvestre 1987	Managing Director/CEO	3.04 % indirectly
LJ Line Suhr Johansen 1986	-	2.97 % indirectly
TA Terje Andre Skulbru 1972	-	2.12 % indirectly
OL Odd-Arne Landevåg 1956	-	1.68 % indirectly
LJ Lars Jon Amundsen 1955	-	1.3 % indirectly

Last update: Dec 10, 2024

Ownership

Company shareholders

Name	Share class	Number of shares	Share
RA Rikard Arne Storvestre 1958	NO0012556192	13,537,500	47.43 %
HR Henrik Rødsand 1960	NO0012556192	4,000,000	14.02 %
S SILAN INVEST AS	NO0012556192	2,400,000	8.41 %
Å ÅLGÅRD OFFSET FINANS AS	NO0012556192	1,600,000	5.61 %
N NOBELSYSTEM SCANDINAVIA AS	NO0012556192	1,272,000	4.46 %
N NETTRAKETT AS	NO0012556192	1,000,000	3.5 %
S STORVESTREINVEST AS	NO0012556192	740,000	2.59 %
X XPANDIR SCANDINAVIA AS	NO0012556192	605,000	2.12 %
S SEAFOOD HOLDING AS	NO0012556192	370,000	1.3 %
S SPIRI AS	NO0012556192	312,500	1.09 %
G GLOBAL PHARMA GROUP AS	NO0012556192	278,716	0.98 %
B BARDUN HOLDING AS	NO0012556192	205,000	0.72 %
H HFA HOLDING AS	NO0012556192	200,000	0.7 %
P PERNOVA HOLDING AS	NO0012556192	175,440	0.61 %
N NORDSTJERNA HOLDING AS	NO0012556192	175,440	0.61 %
L LUTDALGRUPPEN AS	NO0012556192	156,250	0.55 %
ST Svein Tjønsø 1952	NO0012556192	156,250	0.55 %
B BERGSHAGEN INVEST AS	NO0012556192	156,250	0.55 %
B BN GRUPPEN AS	NO0012556192	100,000	0.35 %
G GN POWER INVEST AS	NO0012556192	100,000	0.35 %
TW Tore Ritter Westen 1947	NO0012556192	95,669	0.34 %
W WIDER HOLDING AS	NO0012556192	95,669	0.34 %
MP Morten Pedersen 1965	NO0012556192	81,500	0.29 %
G GUTS HOLDING AS	NO0012556192	78,130	0.27 %
HW Hanne Cecilie Woie 1976	NO0012556192	74,000	0.26 %
PE Per Egil Sørensen 1968	NO0012556192	52,000	0.18 %
H HEIDI HOLMØY INVEST AS	NO0012556192	50,000	0.18 %
L LID VENTILASJON AS	NO0012556192	50,000	0.18 %
TA Trond Arne Pedersen 1963	NO0012556192	40,000	0.14 %
RE Raymond Holm Eriksen 1982	NO0012556192	33,000	0.12 %
IR Ingrid Frantzen Rødsand 1993	NO0012556192	32,530	0.11 %
ER Espen Andreassen Rødsand 1985	NO0012556192	30,530	0.11 %
ER Erlend Andreassen Rødsand 1982	NO0012556192	30,530	0.11 %
AR Andreas Holm Rødsand 1989	NO0012556192	30,530	0.11 %
SE Susanne Holm Eriksen 1980	NO0012556192	30,530	0.11 %
V VALHØGDA INVEST AS	NO0012556192	30,000	0.11 %
DL Daniel Rognan Larsen 1972	NO0012556192	25,000	0.09 %
FA Frank Asle Huth 1959	NO0012556192	20,000	0.07 %
PG Petter Granaas 1956	NO0012556192	16,666	0.06 %
EA Erik Arnesen 1954	NO0012556192	12,000	0.04 %
SJ Sepp Juhani Mantel 1958	NO0012556192	10,000	0.04 %
RG Roar Gløtta 1958	NO0012556192	10,000	0.04 %
S SNARSET INVEST AS	NO0012556192	10,000	0.04 %
TF Tommy Fagerheim 1969	NO0012556192	5,500	0.02 %
TS Torill Susanne Storvestre 1964	NO0012556192	5,500	0.02 %
HS Helene Emilie Storvestre 1952	NO0012556192	5,000	0.02 %
AA Amanda Alessandra Sousa Salberg 1989	NO0012556192	3,000	< 0.01 %
RK Roger Arnesson Kjær 1973	NO0012556192	2,000	< 0.01 %
AL Anette Letmolie 1981	NO0012556192	2,000	< 0.01 %
AN Arvid Kristoffer Nilsen 1981	NO0012556192	2,000	< 0.01 %
AR Astrid Rygg 1979	NO0012556192	2,000	< 0.01 %
BA Bård Arne Brun 1962	NO0012556192	2,000	< 0.01 %
CL Cathrine Lund Larsen 1973	NO0012556192	2,000	< 0.01 %
CW Cecilie Steffensen Woie 1995	NO0012556192	2,000	< 0.01 %
HH Hanne Holen 1976	NO0012556192	2,000	< 0.01 %
IE Ingrid Emma Jakobsen 1997	NO0012556192	2,000	< 0.01 %
KM Kristina Skree Moe 1996	NO0012556192	2,000	< 0.01 %
LM Laila Mortensen 1990	NO0012556192	2,000	< 0.01 %
LW Lisbeth Steffensen Woie 1995	NO0012556192	2,000	< 0.01 %
MT Monika Topaas 1981	NO0012556192	2,000	< 0.01 %
RN Rita Holm Nilsen 1980	NO0012556192	2,000	< 0.01 %
SH Skonseng Stine Hagfors 1991	NO0012556192	2,000	< 0.01 %
TA Tony André Robertsen 1997	NO0012556192	2,000	< 0.01 %
TH Trine Halvorsen 1972	NO0012556192	2,000	< 0.01 %
WO Wilde Opperud 1994	NO0012556192	2,000	< 0.01 %
ÅS Åge Nilsen Sangen 1965	NO0012556192	2,000	< 0.01 %
HP Hilde Kristin Pedersen 1968	NO0012556192	2,000	< 0.01 %
SH Steinar Hansen 1959	NO0012556192	1,000	< 0.01 %
TS Trond Ståle Mathisen 1959	NO0012556192	1,000	< 0.01 %
TH Tormod Hanssen 1950	NO0012556192	1,000	< 0.01 %

Shares owned by the GLOBAL PHARMA GROUP AS

Name	Share class	Number of shares	Share
H HOUZ AS	Ordinary shares	12,000	100 %
I INTERHEALTH SOLUTIONS AS	Ordinary shares	100	100 %
H HERBAL VITAL AS	Ordinary shares	5,000,000	100 %
P PHARMANOVA AS	Ordinary shares	1,000	100 %
H HELSEGRUPPEN AS	Ordinary shares	91	60.67 %
P PHARMA NORGE AS	Ordinary shares	1,610	55.23 %
N NETTRAKETT AS	Ordinary shares	1,501	4.87 %
G GLOBAL PHARMA GROUP AS	NO0012556192	278,716	0.98 %

Last update: May 24, 2024

Group structure

GLOBAL PHARMA GROUP AS
Total operating income 2023: NOK 7,102,055
Operating profit 2023: NOK -4,400,167
Employees: 6

Financials

in NOK

Summary

Year	2023	2022	2021
Total operating income	7,102,055	1,738,117	0
Annual Total Result	-4,118,362	-1,592,256	-205,052
Total assets	80,765,517	18,190,029	10,411,064
Total liabilities	67,934,936	7,117,891	5,621,686
Total equity	12,830,581	11,072,138	4,789,378

P&L

Year	2023	2022	2021
Total operating income	7,102,055	1,738,117	0
Total operating costs	11,502,221	3,586,938	197,841
Operating result	-4,400,167	-1,848,821	-197,841
Financial income/costs	-521,617	-145,665	-60,000
Profit before tax	-4,921,784	-1,994,486	-257,841
Total tax & extraordinary income/cost	-803,422	-402,230	-52,789
Annual Total Result	-4,118,362	-1,592,256	-205,052

Balance overview

Year	2023	2022	2021
Total fixed assets	74,557,232	15,406,633	615,349
Total current assets	6,208,285	2,783,395	9,795,715
Total assets	80,765,517	18,190,029	10,411,064
Short term debt	65,934,936	5,117,891	5,621,686
Long term debt	2,000,000	2,000,000	0
Total liabilities	67,934,936	7,117,891	5,621,686
Contributed capital	2,826,191	11,072,138	4,789,378
Retained earnings	10,004,390	0	0
Total equity	12,830,581	11,072,138	4,789,378
Total equity and liabilities	80,765,517	18,190,029	10,411,064

GLOBAL PHARMA GROUP AS928 006 123

GLOBAL PHARMA GROUP AS

Keywords

Organization

Ownership

Financials

Management

Management / administration

Board

Others

Top 10 individual shareholders

Ownership

Company shareholders

Shares owned by the GLOBAL PHARMA GROUP AS

Group structure

Financials

Summary

P&L

Balance overview

Classification